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Introduction 
Eccrine poromas are benign, adnexal, slow-
growing neoplasms originating from the intra-
epidermal eccrine duct and the acrosyringium. 
These tumors belong to a group of benign eccrine 
ductal tumors that also include hidroacanthoma 
simplex, dermal ductal tumor, and poroid 
hidradenoma. Eccrine poromas account for nearly 
65% of poroid neoplasms and 10% of sweat gland  
tumors [1]. No predilection for race or sex have 
been identified. 
Clinically, an eccrine poroma presents as a single, 
symptomless erythematous papule in areas with a 
high density of eccrine sweat glands such as the 
palms, soles, and fingers. Although rare, eccrine 
poromas can present as multiple lesions, 
otherwise known as eccrine poromatosis. A 
broader distribution that includes the neck, trunk, 
and face may be observed. Newer reports suggest 
that eccrine poromatosis may occur in the setting 
of concurrent or history of chemotherapy, but the 
relationship is unclear [2]. 
We present two cases of eccrine poromatosis in 
patients who had undergone chemotherapy, 
radiation therapy, and stem cell transplant for 
lymphoma. 
 
Case Synopsis 
Case 1 
A 58-year-old man presented to the clinic with 
four pink, pedunculated, exophytic, 2-14mm sized 
papules on his dorsal left foot, right flank, and left 
groin (Figure 1). The patient’s medical history 
included diffuse large B-cell lymphoma with 
several masses including one lesion near the 
hippocampus. He had extensive treatment 10  
Abstract 
Eccrine poroma presents as a single, symptomless 
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Figure 1. Eccrine poromas of the A, B) dorsal left foot and C, D) right flank. 
 
 
Figure 2. Eccrine poroma histopathologic findings of interanastamosing islands of cuboidal cells with occasional ductal 
differentiation. H&E, A) 40× and B) 200×. 
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years prior that included 5 rounds of rituximab, 
cyclop hosphamide, doxorubicin, vincristine, and 
prednisone (R-CHOP); 20 rounds of radiation; 
intrathecal liposomal cytarabine; stem cell 
transplant; and 8 rounds of methotrexate, 
etoposide, and cyclophosphamide. Outside of his 
history of lymphoma, the patient’s past medical 
history was unremarkable. Review of systems was 
also unremarkable. Four shave biopsies were 
performed. Histopathological examination 
demonstrated an epidermis with inter-
anastamosing islands of monotonous appearing 
bland cuboidal cells with occasional ductal 
differentiation (Figure 2). Similar epithelial islands  
were also seen in the dermis. These findings were 
consistent with eccrine poromatosis. No further 
treatment was performed. The patient was then 
lost to follow up. 
Case 2 
A 72-year-old man presented to the clinic with a 
pink eroded papule on the right anterior shoulder 
and a pink and yellow papule on the right upper 
back (Figure 3). The patient’s medical history 
included mantle cell lymphoma 10 years prior for 
which he received high-dose R-CHOP, stem cell 
transplant; he remained on maintenance 
rituximab and lenalidomide. He also had a history 
of prostate cancer 6 years prior for which he 
underwent radical prostatectomy and 
radiotherapy. The patient denied any symptoms 
or trauma to the affected areas. Shave excisions of 
the two papules were performed. 
Histopathological examination demonstrated an 
epidermis with superficial islands of monotonous-
appearing cuboidal cells with epidermal 
interconnection and prominent ductal 
differentiation (Figure 4). These findings were 
consistent with eccrine poromatosis. No further 
treatment was performed. Four years later, there 
is no evidence of recurrence to date. 
 
Figure 4. Eccrine poroma histopathologic findings of an epidermis with superficial islands of monotonous appearing cuboidal 
cells with epidermal interconnection and prominent ductal differentiation. H&E, A) 40× and B) 100×. 
 
 
Figure 3. Eccrine poromas on the right upper back (left) and 
right anterior shoulder (right). 
A B 
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Case Discussion 
Multiple eccrine poromas are an uncommon 
presentation of a rare disease. This case report 
serves to raise awareness of this condition and 
highlight its association with malignancies and 
their treatment. 
Although no definitive etiology for eccrine 
poromatosis has yet been described, possible 
etiologies for the development of multiple eccrine 
poromas include chemotherapy, radiation, actinic 
damage, and human papillomavirus [3]. Indeed, in 
both of our patients, the identified potential 
etiologies among those previously reported were 
a history of high-dose chemotherapy and 
radiation therapy 10 years prior to eccrine 
poromatosis appearance. A recent case of 
eruptive poromatosis in a pregnant woman in her 
third trimester indicates that there could be a 
hormonal association [4]. Others have suspected 
a tumor suppressor gene defect in eccrine cells 
[5]. 
Chemotherapy or radiation therapy may be the 
most likely etiology for eccrine poromatosis. That 
is, a history of chemotherapy and/or radiation 
therapy is often noted in eccrine poromatosis 
cases (Table 1), [2, 3, 5-17]. Although it is 
common for patients to receive both 
chemotherapy and radiation therapy throughout 
the course of their neoplastic treatment, eccrine 
poromatosis most commonly occurs on non-
irradiated skin in patients who received 
polychemotherapy [2]. Additionally, eccrine 
poromatosis developed in patients who received 
chemotherapy without radiation therapy as well. 
Specifically, Yoshii et al. described a case of 
eccrine poromatosis in a patient with systemic 
lupus erythematosus who received 
cyclophosphamide and mizoribine but no 
radiation therapy [18]. 
Chemotherapy is also implicated in the 
development of other eccrine conditions 
including neutrophilic eccrine hidradenitis and 
syringosquamous metaplasia. Previous reports 
suggested that the chemotherapeutic metabolites 
accumulate in the sweat apparatus and are either 
directly cytotoxic to, or induce remodeling in, the 
eccrine sweat glands [2, 19]. Because eccrine 
poromatosis occurs years, sometimes even 
decades, following chemotherapy exposure, it is 
likely that there is a combination of remodeling 
and regeneration that triggers tumor 
development [8]. 
Treatment of eccrine poromas is typically done by 
simple excision. Other successful treatment 
modalities have included electrosurgical 
desiccation, cryotherapy, and imiquimod [4, 9]. 
Eccrine poromas can rarely transform into eccrine 
porocarcinomas. Therefore, careful monitoring or 
treatment by a dermatologist is recommended. 
 
Conclusion 
Eccrine poromatosis is a condition characterized 
by an eruption of multiple eccrine poromas. 
Various etiologies have been discussed in the 
literature. We present two cases of eccrine 
poromatosis in patients who had undergone 
chemotherapy, radiation therapy, and stem cell 
transplant. This case report raises awareness of 
this condition and highlights its association with 
malignancies and their treatment. 
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Table 1. Malignancy-associated eccrine poromatosis. 
Reference 
Age; 
Sex Race Location 
Size 
(mm) 
No. of 
poromas Cancer Treatment of cancer 
Treatment 
of poromas 
Follow up; 
recurrence? 
Fujii et al. 
(2012), [2] 
66; F J 
Bilateral 
thighs, left 
forearm, 
hip, and 
lower 
abdomen 
1-
7mm 
>19 
1. Chronic 
lymphocytic 
leukemia 
2. Follicular 
B-cell 
lymphoma 
(left parotid 
gland, 
mediastinum, 
and para-
aortic lymph 
nodes) 
1. Cyclophosphamide 
and “other 
chemotherapeutic 
regimens” 
2. Epirubicin, 
vincristine, 
mitoxantrone, 
cyclophosphamide, 
methotrexate, 
prednisolone, 
etoposide, cisplatin, 
and “unidentified 
regimens” 
3. Surgical resection 
and radiation therapy 
to right eyelid 
N/A N/A 
Fujii et al. 
(2012), [2] 
62; 
M 
N/A 
Left lower 
leg, right 
heel, and 
right sole 
4-
7mm 
3 
Malignant 
fibrous 
histiocytoma 
(right thigh) 
Wide resection of 
right thigh, 
doxorubicin, 
ifosfamide. and 
radiation therapy to 
right leg 
Excisional 
biopsy 
N/A 
Fujii et al. 
(2012), [2] 
59; 
M 
J 
Right palm, 
left hand, 
and sole 
and heel of 
left foot 
3-
15m
m 
4 
Malignant B-
cell 
lymphoma 
CHOP, methotrexate, 
and rituximab 
Biopsy 
and 
resection 
N/A 
Fujii et al. 
(2012), [2] 
72; 
M 
J 
Back, right 
thigh, right 
knee, trunk, 
and 
extremities 
2-
15mm 
>5 
Diffuse large 
B-cell 
lymphoma 
CHOP and etoposide 
Excisional 
biopsy 
N/A 
Deckelbaum 
et al. 
(2014), [3] 
73; 
M 
N/A Soles N/A 30 
Testicular 
lymphoma 
CHOP and radiation 
Excisional 
biopsy 
N/A 
Mahlberg 
et al. 
(2006), [5] 
42; 
M 
N/A 
Distal 
extremities, 
primarily 
palms and 
left sole 
4-
16mm 
14 
Acute 
lymphocytic 
leukemia 
Chemotherapy, total 
body irradiation, and 
allogenic bone 
marrow transplant.  
Shave 
biopsy 
N/A 
Navi et al. 
(2008), [6] 
64; 
M 
N/A 
Chest, left 
nipple, 
eyelid, left 
forearm, 
and left 
ankle 
N/A 7 
Non-Hodgkin 
lymphoma 
with history 
of colorectal 
carcinoma 
CHOP and rituximab 
Shave 
biopsy 
and 
complete 
excision 
N/A 
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Diamantis 
et al. 
(2011), [7] 
53; 
M 
N/A 
Palms, left 
elbow, and 
heels 
2-
6mm 
6 
Mantle cell 
lymphoma 
Allogenic stem cell 
transplant. 
Photopheresis, 
tacrolimus, systemic 
corticosteroids, and 
mycophenolate 
mofetil for chronic 
graft-versus-host 
disease 
Shave 
biopsy 
N/A 
Valdebran 
et al. 
(2018), [8] 
32; F N/A 
Feet and 
lower eyelid 
1-
2mm 
17 
Acute 
promyelocyti
c leukemia 
Tretinoin, 
amphotericin B, 
busulfan, etoposide, 
arsenic trioxide, 
cytarabine, and bone 
marrow stem cell 
transplant 
Mild 
electroca
uterizatio
n 
N/A 
Mayo et 
al. (2015), 
[9] 
43; 
M 
AA 
Bilateral 
plantar feet, 
hands, and 
arms 
1-
9mm 
16 
Mantle cell 
lymphoma 
Cyclophosphamide, 
vincristine, 
doxorubicin, 
dexamethasone, 
methotrexate, 
cytarabine, and 
autologous stem cell 
transplant (pre-
transplant regimen of 
busulfan, 
cyclophosphamide, 
and etoposide) 
Excision 
to four 
eccrine 
poromas, 
imiquimo
d 5% 
cream 
and 
cryosurg
ery 
ablation 
N/A 
Kurokawa 
et al. 
(2001), 
[10] 
72; 
M 
N/A 
Bilateral 
thighs, right 
lumbus, left 
elbow, left 
brachium, 
left leg, 
bilateral 
shoulders, 
left buttock, 
left inguinal 
region, and 
left breast 
3-
8mm 
14 
Mycosis 
fungoides 
Whole body electron 
beam irradiation 
(except for the head), 
regional electron 
beam irradiation 
(bilateral lower 
extremities, right 
antebrachium, left 
palm, left 
antebrachium, trunk, 
and buttocks), and 
interferon-γ1a 
Shave 
biopsy 
and 
observati
on 
>2 years 
with no 
changes 
Miura et 
al. (2013), 
[11] 
72; F N/A 
Abdomen, 
trunk, neck, 
and 
extremities 
5mm 11 
Nasolacrimal 
duct 
adenocarcino
ma 
Radical excision and 
post-operative 
radiation therapy 
Surgical 
removal 
under 
anesthesi
a 
N/A 
Nguyen 
et al. 
(2012), 
[12] 
25; 
M 
N/A 
Right dorsal 
foot, right 
medial foot, 
both soles, 
N/A 8 
Acute 
myelogenous 
leukemia 
Autologous bone 
marrow transplant 
Salicylic 
acid (did 
not 
respond) 
and 
N/A 
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and both 
heels 
shave 
biopsy 
Garshick 
et al. 
(2014), 
[13] 
46; 
M 
N/A 
Palms and 
soles 
2-
5mm 
22 
Acute 
myeloid 
leukemia 
Cytarabine, 
daunorubicin, 
etoposide, and 
autologous stem cell 
transplant 
Shave 
excision 
N/A 
Takahashi 
et al. 
(2015), 
[14] 
63; F N/A 
Right thigh, 
lower 
abdomen, 
left forearm, 
and bilateral 
calves 
1-
12mm 
≥5 
Acute 
myelocytic 
leukemia 
Idarubicin, cytarabine, 
prednisolone, and 
autologous 
peripheral blood 
stem cell transplant 
Excision N/A 
Sherman 
et al. 
(2010), 
[15] 
32; 
M 
N/A 
Left great 
toe, right 5th 
toe, left 
sole, and 
webspace 
between left 
4th and 5th 
toe 
2-
8mm 
4 
1. Testicular 
teratoma 
with para-
aortic and 
supraclavicul
ar lymph 
node 
involvement 
and 
pulmonary 
metastasis 
2. Acute 
myeloid 
leukemia 
3. Squamous 
cell 
carcinoma of 
esophagus 
1. Orchidectomy, 
bleomycin, cisplatin, 
and etoposide 
2. Cytarabine, 
daunorubicin, 
etoposide, allogenic 
bone marrow 
transplant (preceded 
by cyclophosphamide 
and total body 
irradiation), and 
fludarabine. Second 
allogenic bone 
marrow transplant 
(melphalan and 
fludarabine).  
3. Ivor-Lewis 
esophagectomy  
4. Prednisolone and 
cyclosporine (for 
graft-versus-host 
disease) 
Curettag
e and 
shave 
excision 
>8 years 
no 
recurren
ce 
Lim et al. 
(2018), 
[16] 
63; F N/A 
Left thigh, 
left buttock, 
left breast, 
left 
clavicular 
region, left 
hand and 
fingers, left 
forearm, left 
lateral neck, 
right arm, 
right 
temple, and 
scalp 
N/A >18 
Metastatic 
right breast 
cancer 
Mastectomy, 5-
fluorouracil, 
epirubicin, 
cyclophosphamide, 
letrozole, paclitaxel, 
trastuzumab, 
pertuzumab, 
tamoxifen, resection 
of right infraclavicular 
mass, and radiation 
therapy to right chest 
wall, axilla, and 
supraclavicular fossa 
Shave 
excision 
N/A 
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Aung et 
al. (2017), 
[17] 
45; 
M 
N/A 
Toes, heels, 
and fingers 
3-
6mm 
>3 
Acute 
myeloid 
leukemia 
Chemotherapy and 
allogenic stem cell 
transplant 
Biopsy N/A 
AA= African American; CHOP= Cyclophosphamide, doxorubicin, vincristine, and prednisolone; J= Japanese; mm= millimeter; No.= 
Number of poromas; Ref.=Reference, Tx= Treatment. 
 
